CA
AVNS

Clearstead Advisors’s Avanos Medical AVNS Stock Holding History

Clearstead Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$113 – 2302
2025
Q4 		$113 Sell
10
-1,258
-99% -$14.4K ﹤0.01% 2501
2025
Q3 		$14.7K Buy
1,268
+874
+222% +$10.2K ﹤0.01% 1776
2025
Q2 		$4.82K Buy
+394
New +$4.96K ﹤0.01% 2116

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Clearstead Advisors's AVNS Position: Q1 2026 in Review

Clearstead Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 10 shares — an estimated $113 sold.

Clearstead Advisors first reported a position in AVNS in Q2 2025 and held it in 3 quarters. The position peaked at $14.7K in Q3 2025. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Clearstead Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Clearstead Advisors sold 10 Avanos Medical shares in Q1 2026, an estimated $113.
  • Clearstead Advisors first reported a position in Avanos Medical in Q2 2025 and held it in 3 quarters.
  • Clearstead Advisors's Avanos Medical position peaked at $14.7K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.